Abstract
Background
Bariatric surgery has demonstrated to be effective in remission of type 2 diabetes in obese patients, but it is unclear in non-obese patients. The aim of this study is to investigate if metabolic surgery is effective in diabetes resolution in patients with BMI < 30 kg/m2.
Materials and Methods
A systematic review was performed and the content of the PubMed, Ovid, and the Cochrane Library databases covering the period January 2008 to April 2018 was searched. Studies with metabolic surgery performed in patients with type 2 diabetes, BMI < 30 kg/m2 and a follow-up ≥ 6 months were included. Type 2 diabetes remission rate and metabolic parameters changes were measured. A meta-analysis was conducted with the selected studies.
Results
Twenty-six studies were included in the meta-analysis (1105 patients). The mixed-effects meta-analysis model for overall diabetes remission rate produced an estimate of 43% (95% IC 34–53%, p < 0.001). Moderator effects of the variables race, preoperative HbA1c, BMI, months of follow-up, duration of diabetes, and age on diabetes remission were also assessed, with no significant effects being found in any of them. A reduction in BMI (− 3.57 kg/m2), fasting blood glucose (− 55.93 mg/dL) and HbA1c (− 2.08%) was observed after surgery.
Conclusions
Metabolic surgery could be effective in remission of type 2 diabetes in BMI < 30 kg/m2 patients but randomized and long-term studies are necessary. The scientific community should agree in a single definition of type 2 diabetes remission, in order to know the real effect of metabolic surgery in this group of patients.
Similar content being viewed by others
References
NCD Risk Factor Collaboration (NCD RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513–30.
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77.
Cohen R, Le Roux CW, Junqueira S, et al. Roux-en-Y gastric bypass in type 2 diabetes patients with mild obesity: a systematic review and meta-analysis. Obes Surg. 2017;27:2733–9.
Cummings DE, Cohen RV. Bariatric/metabolic surgery to treat type 2 diabetes in patients with BMI <35 kg/m2. Diabetes Care. 2016;39:924–33.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
The Otawa Hospital Research Institute [Internet]. Canada, The Otawa Hospital; [Cited 2018, July 16]. Avaliable from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
DePaula AL, Stival AR, DePaula CC, et al. Impact on dyslipidemia of the laparoscopic ileal interposition associated to sleeve gastrectomy in type 2 diabetic patients. J Gastrointest Surg. 2010;14:1319–25.
Navarrete SA, Leyba JL, Llopis SN. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients. Obes Surg. 2011;21:663–7.
Scopinaro N, Adami GF, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study. Obes Surg. 2011;21:880–8.
Geloneze B, Geloneze SR, Chaim E, et al. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg. 2012;256:72–8.
García-Caballero M, Valle M, Martínez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass. Nutr Hosp. 2012;27:623–31.
Heo Y, Ahn JH, Shin SH, et al. The effect of duodenojejunal bypass for type 2 diabetes mellitus patients below body mass index 25 kg/m2: one year follow-up. J Korean Surg Soc. 2013;85:109–15.
Astiarraga B, Gastaldelli A, Muscelli E, et al. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab. 2013;98:2765–73.
Dixon JB, Hur KY, Lee WJ, et al. Gastric bypass in type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes. Diabet Med. 2013;30:e127–34.
Chen W, Yan Z, Liu S, et al. The better effect of Roux-en-Y gastrointestinal reconstruction on blood glucose of nonobese type 2 diabetes mellitus patients. Am J Surg. 2014;207:877–81.
Kim MJ, Hur KY. Short-term outcomes of laparoscopic single anastomosis gastric bypass (LSAGB) for the treatment of type 2 diabetes in lower BMI (<30 kg/m2) patients. Obes Surg. 2014;24:1044–51.
Malapan K, Goel R, Tai CM, et al. Laparoscopic Roux-en-Y gastric bypass for nonobese type II diabetes mellitus in Asian patients. Surg Obes Relat Dis. 2014;10:834–40.
Ugale S, Gupta N, Modi KD, et al. Prediction of remission after metabolic surgery using a novel scoring system in type 2 diabetes - a retrospective cohort study. J Diabetes Metab Disord. 2014;13:89.
Wentworth JM, Playfair J, Laurie C, et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial. Lancet Diabetes Endocrinol. 2014;2:545–52.
Yin J, Xu L, Mao Z, et al. Laparoscopic Roux-en-Y gastric bypass for type 2 diabetes mellitus in nonobese Chinese patients. Surg Laparosc Endosc Percutan Tech. 2014;24:e200–6.
Cui JF, Chen T, Shi L, et al. Gastric bypass surgery in non-obese patients with type 2 diabetes mellitus: a 1-year follow-up of 58 cases in Chinese. Int J Clin Exp Med. 2015;8:4393–8.
Liang H, Guan W, Yang Y, et al. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m2: a multi-institutional study. J Biomed Res. 2015;29:112–7.
Lee WJ, Almulaifi A, Chong K, et al. The effect and predictive score of gastric bypass and sleeve gastrectomy on type 2 diabetes mellitus patients with BMI < 30 kg/m2. Obes Surg. 2015;25:1772–8.
Kwon O, Lee YJ, Yu JH, et al. The recovery of beta-cell function is critical for antidiabetic outcomes of gastric bypass in Asian subjects with type 2 diabetes and a body mass index below 30. Obes Surg. 2017;27:541–4.
Wang G, Zhu L, Li W, et al. Can low BMI Chinese patients with type 2 diabetes benefit from laparoscopic Roux-en-Y gastric bypass surgery? Surg Obes Relat Dis. 2016;12:1890–5.
Celik A, Cagiltay E, Ugale S, et al. Diverted sleeve gastrectomy with ileal transposition in overweight, obese, and morbidly obese patients with type 2 diabetes: results of 1-year follow-up. Surg Obes Relat Dis. 2016;12:541–9.
Di J, Zhang H, Yu H, et al. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m2. Surg Obes Relat Dis. 2016;12:1357–63.
Ramakrishnapillai P, Pai M, Shams F, et al. Effectiveness of minimally invasive hybrid surgery for ileal interposition (MIHSII) for the resolution of type 2 diabetes. Surg Innov. 2016;23:42–51.
Zhang H, Han X, Yu H, et al. Effect of Roux-en-Y gastric bypass on remission of T2D: medium-term follow-up in Chinese patients with different BMI obesity class. Obes Surg. 2017;27:134–42.
Kim DJ, Paik KY, Kim MK, et al. Three-year result of efficacy for type 2 diabetes mellitus control between laparoscopic duodenojejunal bypass compared with laparoscopic Roux-en-Y gastric bypass. Ann Surg Treat Res. 2017;93:260–5.
Gong K, Li K, Zhang N, et al. Gastric bypass procedure for type 2 diabetes patients with BMI <28 kg/m2. Surg Endosc. 2017;31:1172–9.
Ke Z, Li F, Chen J, et al. Effects of laparoscopic Roux-en-Y gastric bypass for type 2 diabetes mellitus: comparison of BMI > 30 and < 30 kg/m2. Obes Surg. 2017;27:3040–7.
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
American Diabetes Association. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S65–72.
Batterham RL, Cummings DE. Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care. 2016;39:893–901.
Cummings DE, Rubino F. Metabolic surgery for treatment of type 2 diabetes in obese individuals. Diabetologia. 2018;61:257–64.
Rao WS, Shan CX, Zhang W, et al. A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass. World J Surg. 2015;39:223–30.
Panunzi S, De Gaetano A, Carnicelli A, et al. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg. 2015;261:459–67.
Lakdawala M, Shaikh S, Bandukwala S, et al. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m2) Indian patients with type 2 diabetes mellitus. Surg Obes Relat Dis. 2013;9:370–8.
Hsu CC, Almulaifi A, Chen JC, et al. Effect of bariatric surgery vs medical treatment on type 2 diabetes in patients with body mass index lower than 35: five-year outcomes. JAMA Surg. 2015;150:1117–24.
Huang ZP, Guo Y, Liu CQ, et al. The effect of metabolic surgery on nonobese patients (BMI<30 kg/m2) with type 2 diabetes: a systematic review. Surg Obes Relat Dis. 2018;14:810–20.
Baskota A, Li S, Dhakal N, et al. Bariatric surgery for type 2 diabetes mellitus in patients with BMI <30 kg/m2: a systematic review and meta-analysis. PLoS One. 2015;10:e0132335.
Kang JH, Le QA. Effectiveness of bariatric surgical procedures: a systematic review and network meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017;96:e8632.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interests.
Ethical Approval Statement
For this type of study, formal consent is not required.
Informed Consent Statement
Informed consent statement does not apply.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Supplementary table
Newcastle-Otawa scale. Quality assessment of the included studies in the meta-analysis. S1: Representativeness of the exposed cohort; S2: Selection of the non-exposed cohort; S3: Ascertainment of exposure; S4: Demonstration that outcome of interest was not present at start of study. O1: Assessment of outcome; O2: Was follow-up long enough for outcomes to occur; O3: Adequacy of follow up of cohorts (DOCX 26 kb)
Rights and permissions
About this article
Cite this article
Rubio-Almanza, M., Hervás-Marín, D., Cámara-Gómez, R. et al. Does Metabolic Surgery Lead to Diabetes Remission in Patients with BMI < 30 kg/m2?: a Meta-analysis. OBES SURG 29, 1105–1116 (2019). https://doi.org/10.1007/s11695-018-03654-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-018-03654-x